Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

534 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors.
Antonini S, Pedersini R, Birtolo MF, Baruch NL, Carrone F, Jaafar S, Ciafardini A, Cosentini D, Laganà M, Torrisi R, Farina D, Leonardi L, Balzarini L, Vena W, Bossi AC, Zambelli A, Lania AG, Berruti A, Mazziotti G. Antonini S, et al. Among authors: berruti a. J Endocrinol Invest. 2024 Mar;47(3):759. doi: 10.1007/s40618-023-02208-y. J Endocrinol Invest. 2024. PMID: 37814065 No abstract available.
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study.
Delbarba A, Cosentini D, Facondo P, Laganà M, Pezzaioli LC, Cremaschi V, Alberti A, Grisanti S, Cappelli C, Ferlin A, Berruti A. Delbarba A, et al. Among authors: berruti a. Front Endocrinol (Lausanne). 2023 Apr 5;14:1128061. doi: 10.3389/fendo.2023.1128061. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37077359 Free PMC article.
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors.
Antonini S, Pedersini R, Birtolo MF, Baruch NL, Carrone F, Jaafar S, Ciafardini A, Cosentini D, Laganà M, Torrisi R, Farina D, Leonardi L, Balzarini L, Vena W, Bossi AC, Zambelli A, Lania AG, Berruti A, Mazziotti G. Antonini S, et al. Among authors: berruti a. J Endocrinol Invest. 2024 Feb;47(2):433-442. doi: 10.1007/s40618-023-02174-5. Epub 2023 Aug 17. J Endocrinol Invest. 2024. PMID: 37592052
The Evolving Treatment Landscape of Medullary Thyroid Cancer.
Laganà M, Cremaschi V, Alberti A, Vodopivec Kuri DM, Cosentini D, Berruti A. Laganà M, et al. Among authors: berruti a. Curr Treat Options Oncol. 2023 Dec;24(12):1815-1832. doi: 10.1007/s11864-023-01145-5. Epub 2023 Nov 18. Curr Treat Options Oncol. 2023. PMID: 37979019 Free PMC article. Review.
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis.
Pedersini R, Buffoni M, Petrelli F, Ghidini A, di Mauro P, Amoroso V, Parati MC, Laini L, Cosentini D, Schivardi G, Ippolito G, Berruti A, Laganà M. Pedersini R, et al. Among authors: berruti a. Clin Breast Cancer. 2024 Jul;24(5):411-420. doi: 10.1016/j.clbc.2024.04.003. Epub 2024 Apr 8. Clin Breast Cancer. 2024. PMID: 38734491 Free article. Review.
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide.
Dalla Volta A, Valcamonico F, Zivi A, Procopio G, Sepe P, Del Conte G, Di Meo N, Foti S, Zamboni S, Messina C, Lucchini E, Rizzi A, Ravanelli M, Calza S, Zacchi F, Ciccone G, Suardi N, Maroldi R, Farina D, Berruti A. Dalla Volta A, et al. Among authors: berruti a. Eur Urol. 2024 Sep;86(3):268-271. doi: 10.1016/j.eururo.2024.05.004. Epub 2024 May 20. Eur Urol. 2024. PMID: 38772788 No abstract available.
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study.
Terzolo M, Fassnacht M, Perotti P, Libé R, Kastelan D, Lacroix A, Arlt W, Haak HR, Loli P, Decoudier B, Lasolle H, Quinkler M, Haissaguerre M, Chabre O, Caron P, Stigliano A, Giordano R, Zatelli MC, Bancos I, Fragoso MCBV, Canu L, Luconi M, Puglisi S, Basile V, Reimondo G, Kroiss M, Megerle F, Hahner S, Kimpel O, Dusek T, Nölting S, Bourdeau I, Chortis V, Ettaieb MH, Cosentini D, Grisanti S, Baudin E, Berchialla P, Bovis F, Sormani MP, Bruzzi P, Beuschlein F, Bertherat J, Berruti A. Terzolo M, et al. Among authors: berruti a. Lancet Diabetes Endocrinol. 2023 Oct;11(10):720-730. doi: 10.1016/S2213-8587(23)00193-6. Epub 2023 Aug 21. Lancet Diabetes Endocrinol. 2023. PMID: 37619579 Free PMC article. Clinical Trial.
New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort Study.
Puglisi S, Calabrese A, Ferraù F, Violi MA, Laganà M, Grisanti S, Ceccato F, Scaroni C, Di Dalmazi G, Stigliano A, Altieri B, Canu L, Loli P, Pivonello R, Arvat E, Morelli V, Perotti P, Basile V, Berchialla P, Urru S, Fiori C, Porpiglia F, Berruti A, Pia A, Reimondo G, Cannavò S, Terzolo M. Puglisi S, et al. Among authors: berruti a. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2517-2525. doi: 10.1210/clinem/dgad199. J Clin Endocrinol Metab. 2023. PMID: 37022947
534 results